EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Clozapine-Associated Generalized Seizure at Therapeutic Dose Without Prior Epilepsy: A Case Report

Kebron W Aweke iD, Yonathan Belay Kebede, Elias Getahun Bayu, Fraol Dereje Bekele, Zaki Abate Zimme, Ermias Fikru Mamo, Mikiyas G Teferi iD

Clinical Medicine Insights: Case Reports · 2026-07 · 19

DOI: 10.1177/11795476261467702 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Medicine Insights: Case Reports, online erschienen am 08.07.2026. Verfasst von Kebron W Aweke und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia but is associated with a dose-dependent reduction in seizure threshold. While seizures are typically linked to high doses or rapid titration, events at therapeutic doses remain clinically significant and poorly characterized, particularly in resource-limited settings. Case presentation We report a 35-year-old Ethiopian man with treatment-resistant schizophrenia stabilized on clozapine 300 mg/day for 8 months who presented with a first generalized tonic–clonic seizure. There was no prior seizure history. Laboratory evaluation and neuroimaging were unremarkable. Electroencephalography (EEG) demonstrated generalized spike–wave discharges with photoparoxysmal response, suggesting underlying epileptiform susceptibility. Clozapine serum levels were unavailable. After exclusion of alternative causes, the event was considered likely clozapine-associated. Clozapine dose was reduced to 200 mg/day and sodium valproate initiated. The patient remained seizure-free at 6-month follow-up with preserved psychiatric stability.

Conclusion

Clozapine may precipitate seizures at therapeutic doses in patients with latent epileptiform susceptibility. When therapeutic drug monitoring is unavailable, careful clinical assessment, EEG evaluation, and exclusion of alternative causes are essential. Dose reduction with anticonvulsant therapy may permit safe continuation of clozapine.

Schlagwörter

Stichwörter der Autor:innen

adverse drug reactioncase reportclozapineelectroencephalographyschizophreniaseizure

Autor:innen und Institutionen

  • School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
  • Arba Minch University, College of Medicine and Health Sciences, Arba Minch, Ethiopia.
  • Johns Hopkins Bloomberg School of Public Health, Maryland, Baltimore, USA.
  • University of Gondar, College of Medicine and Health Sciences, Gondar, Ethiopia.
  • School of Medicine, Hayat Medical College, Addis Ababa, Ethiopia.

ORCID-Profile: Kebron W Aweke, Mikiyas G Teferi

Zitieren

APA

Aweke, K. W., Kebede, Y. B., Bayu, E. G., Bekele, F. D., Zimme, Z. A., Mamo, E. F., & Teferi, M. G. (2026). Clozapine-Associated Generalized Seizure at Therapeutic Dose Without Prior Epilepsy: A Case Report. Clinical Medicine Insights: Case Reports, 19. https://doi.org/10.1177/11795476261467702

Vancouver

Aweke KW, Kebede YB, Bayu EG, Bekele FD, Zimme ZA, Mamo EF, et al. Clozapine-Associated Generalized Seizure at Therapeutic Dose Without Prior Epilepsy: A Case Report. Clinical Medicine Insights: Case Reports. 2026;19. doi:10.1177/11795476261467702

BibTeX
@article{Aweke2026,
  author = {Aweke, Kebron W and Kebede, Yonathan Belay and Bayu, Elias Getahun and Bekele, Fraol Dereje and Zimme, Zaki Abate and Mamo, Ermias Fikru and Teferi, Mikiyas G},
  title = {Clozapine-Associated Generalized Seizure at Therapeutic Dose Without Prior Epilepsy: A Case Report},
  journal = {Clinical Medicine Insights: Case Reports},
  year = {2026},
  volume = {19},
  doi = {10.1177/11795476261467702}
}
Kostenlos starten →